NPS completes patient randomization in GATTEX Phase 3 study for PN dependent short boInformation on NPS completes patient randomization in GATTEX Phase 3 study for PN dependent short bo under Bowel Disorders section of the Health Articles & Reviews; NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of patient randomization in its Phase ... |
 |
|
NPS completes patient randomization in GATTEX Phase 3 study for PN dependent short bo
by Ellen_Toon 07-23-2010, 07:41 PM
NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of patient randomization in its Phase 3 registration study of GATTEX (teduglutide). The double-blind, placebo-controlled safety and efficacy study, which is known as STEPS, is being conducted in patients with parenteral ...
More... |
Views 15
Comments 0
|
|
| Bookmarks |
| Currently Active Users Viewing This Article: 1 (0 members and 1 guests) | |
| Article Tools | |
| Display Modes | |
|
|
 |  |  |  |
 |  |  |  |
 |  |  |  |
 |  |  |  |
 |  |  |  |
Linear Mode
